Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement
Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement
NEW YORK, NY, April 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI) (the "Company"), a leader in smart building technology solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors. The Company issued shares of common stock of the Company ("Common Stock") and pre-funded warrants ("Pre-Funded Warrants") in a registered direct offering. In a concurrent private placement, the Company also issued common warrants ("Common Warrants") to the same investors. Aggregate gross proceeds to the Company from both transactions were approximately $2.76 million. The transactions closed on April 1, 2024. The transactions were priced at the market under Nasdaq rules.
纽约州纽约,2024年4月1日(GLOBE NEWSWIRE)——通过NewMediaWire,智能建筑技术解决方案领域的领导者应用紫外线有限公司(纳斯达克股票代码:AUVI)(“公司”)今天宣布结束其先前宣布的注册直接发行和与机构投资者的同步私募配售。公司以注册直接发行方式发行了公司普通股(“普通股”)和预先注资的认股权证(“预融资认股权证”)。在同时进行的私募中,公司还向同一投资者发行了普通认股权证(“普通认股权证”)。公司从两笔交易中获得的总收益约为276万美元。这些交易于 2024 年 4 月 1 日结束。这些交易是根据纳斯达克的规定在市场上定价的。
The transactions consisted of (i) the public sale of an aggregate of 1,726,875 shares of Common Stock (or Pre-Funded Warrants in lieu thereof) and (ii) the private placement of Common Warrants to purchase up to 518,065 shares of Common Stock at an initial exercise price of $16.00 per share. The public offering price per share of Common Stock is $1.60 (or $1.5999 for each Pre-Funded Warrant, which is equal to the public offering price per share of Common Stock to be sold in the offering minus an exercise price of $0.0001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. The Common Warrants are exercisable immediately subject to registration and expire 5 years after the initial issuance date. The Company expects to use the net proceeds from the offering to help fund recent large orders within the Smart Building Technologies division from customers including: Siemens, Sherwin Williams and Arco Murray and other general corporate purposes.
这些交易包括(i)公开发售总计1,726,875股普通股(或取而代之的预融资认股权证),以及(ii)私募普通认股权证,以每股16.00美元的初始行使价购买多达518,065股普通股。普通股每股公开发行价格为1.60美元(或每份预筹认股权证1.599美元,等于本次发行中出售的每股普通股的公开发行价格减去每份预先注资认股权证0.0001美元的行使价)。预先注资的认股权证可立即行使,并可随时行使,直至全部行使。普通认股权证可在注册后立即行使,并在首次发行之日起5年后到期。该公司预计将使用此次发行的净收益为智能建筑技术部门最近从西门子、宣文·威廉姆斯和Arco Murray等客户那里订购的大宗订单以及其他一般公司用途提供资金。
Aegis Capital Corp. acted as the exclusive placement agent for the offerings. Sichenzia Ross Ference Carmel LLP acted as counsel to the Company for the offerings. Kaufman & Canoles, P.C. acted as counsel to the Placement Agent for the offerings.
Aegis Capital Corp. 担任此次发行的独家配售代理。Sichenzia Ross Ference Carmel LLP担任该公司的发行法律顾问。Kaufman & Canoles, P.C. 担任发行代理人的法律顾问。
The registered direct offering was being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-266015) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on July 12, 2022. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering has been filed with the SEC and will be available on the SEC's website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.
本次注册直接发行是根据先前向美国证券交易委员会(SEC)提交并由美国证券交易委员会(SEC)宣布于2022年7月12日生效的S-3表格(编号333-266015)上的有效货架注册声明进行的。描述拟议发行条款的最终招股说明书补充文件和随附的招股说明书已向美国证券交易委员会提交,并将在美国证券交易委员会的网站上公布,网址为 www.sec.gov。最终招股说明书补充文件和随附的招股说明书的电子副本(如果有)可以通过以下方式获取:纽约州纽约10105号美洲大道1345号27楼辛迪加部,发送电子邮件至 syndicate@aegiscap.com,或致电+1 (212) 813-1010。
The offer and sale of the securities in the private placement were made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the Common Stock and the Shares issuable upon exercise of the pre-funded warrants and warrants.
私募证券的发行和出售是在不涉及公开发行的交易中进行的,也没有根据经修订的1933年《证券法》(“证券法”)或适用的州证券法进行登记。因此,除非根据有效的注册声明或《证券法》和此类适用的州证券法注册要求的适用豁免,否则不得在美国再发行或转售这些证券。这些证券仅向合格投资者发行。根据与投资者的注册权协议,公司已同意向美国证券交易委员会提交一份或多份注册声明,内容涉及普通股的转售以及行使预先注资的认股权证和认股权证后可发行的股份。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新闻稿不构成出售要约或招揽买入要约,在根据任何此类州或司法管辖区的证券法进行注册或资格认证之前,此类要约、招标或出售是非法的,则不得在任何州或司法管辖区出售这些证券。
About Applied UV, Inc.
关于应用紫外线公司
Applied UV Inc. is dedicated to developing and acquiring smart building technologies for healthcare, hospitality, commercial and municipal markets. With SteriLumen, MunnWorks, LED Supply Co., and PURO, the company has a diverse portfolio that addresses various needs in the market. Applied UV Inc. is committed to innovation and excellence in providing solutions for a healthier and smarter world. More details about Applied UV, Inc., and its subsidiaries can be found at
Applied UV Inc. 致力于为医疗保健、酒店、商业和市政市场开发和收购智能建筑技术。凭借SteriluMen、MunnWorks、LED Supply Co. 和PURO,该公司拥有多元化的产品组合,可以满足市场的各种需求。Applied UV Inc. 致力于创新和卓越,为更健康、更智能的世界提供解决方案。有关Applied UV, Inc. 及其子公司的更多详细信息,请访问
Forward-Looking Statements
前瞻性陈述
The foregoing material may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company's product development and business prospects, and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.
上述材料可能包含经修订的1933年《证券法》第27A条和1934年《证券交易法》第21E条所指的 “前瞻性陈述”。前瞻性陈述包括所有不只与历史或当前事实相关的陈述,包括但不限于有关公司产品开发和业务前景的陈述,可以通过使用 “可能”、“将”、“期望”、“项目”、“估计”、“预测”、“计划”、“相信”、“潜力”、“应该”、“继续” 等词语或这些词语或其他类似词语的负面版本来识别。前瞻性陈述并不能保证未来的行动或业绩。这些前瞻性陈述基于公司目前获得的信息及其当前的计划或预期,并存在许多风险和不确定性,这些风险和不确定性可能会对当前计划产生重大影响。如果其中一项或多项风险或不确定性成为现实,或者基本假设被证明不正确,则实际结果可能与预期、相信、估计、预期、预期或计划的结果存在显著差异。尽管公司认为前瞻性陈述中反映的预期是合理的,但公司无法保证未来的业绩、业绩或成就。除非适用法律(包括美国证券法)要求,否则公司无意更新任何前瞻性陈述以使这些陈述与实际业绩保持一致。
For Additional Company Information:
Applied UV, Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
有关其他公司信息:
Applied UV, Inc.
Max Munn
应用紫外线创始人、首席执行官兼董事
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
投资者关系联系人:
traDigital
凯文麦格拉思
+1-646-418-7002
kevin@tradigitalir.com